VivaTest

Research and development in drug delivery technology and pharmaceutical services.

About VivaTest

VivaTest is a Healthcare company. Research and development in drug delivery technology and pharmaceutical services. Its Indian entity Vivatest Research And Development Private Limited reported revenue of β‚Ή1.67 Cr. VivaTest offers products and services including Formulation Development and Analytical Development. Its focus areas include Biotechnology, Research and Development, Analytical Services and Pharmaceuticals.

Company details

VivaTest is identified as a provider of research-based drug delivery technologies, where services in formulation development, analytical processes, and stability assessments are offered to enhance drug efficacy. Partnerships for BABE studies and dossier services are extended by its experienced directors, positioning it as a comprehensive service provider in pharmaceutical research and outsourcing. Technologies aimed at improving bioavailability and release profiles are supplied, with a focus on end-to-end solutions for global partners.

Key Metrics
  • Indian entity revenue
    ₹1.67 Cr

    FY 2024 · -16% YoY

  • Indian entity net profit
    ₹6.2 Lakh

    FY 2024 · 4% margin

  • Indian entity EBITDA
    ₹36.4 Lakh

    FY 2024 · 22% margin

Products & Services of VivaTest

VivaTest offers a comprehensive portfolio of products and services, including Formulation Development and Analytical Development.

Formulation Development
Drug Development Services

Formulation development services are provided to improve drug delivery technologies.

Analytical Development
Research Services

Analytical development is conducted for stability evaluations and technology transfer in pharmaceutical processes.

Board of directors of Vivatest Research And Development Private Limited (VivaTest)

Vivatest Research And Development Private Limited is the primary company behind VivaTest. The board of Vivatest Research And Development Private Limited currently have 3 directors; the longest-serving is Kirtida Radhakrishna Desai, appointed in 2014. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kirtida Radhakrishna Desai
DIN 06953567
Director25 Nov 201411 yrs 11 moVivatest Research And Development Private Limited
Analesh Anand Desai
DIN 06957572
Director25 Nov 201411 yrs 11 moVivatest Research And Development Private Limited
Geeta Radhakrishna Desai
DIN 07777819
Additional Director27 Mar 20179 yrs 7 moVivatest Research And Development Private Limited

Financials of VivaTest

Figures of Vivatest Research And Development Private Limited, the primary company behind VivaTest, for FY 2024. Revenue was ₹1.67 Cr (-16% year on year). Net profit was ₹6.2 Lakh (4% margin). EBITDA was ₹36.4 Lakh (22% margin). Revenue has grown at a compounded annual rate of -18% over three years.

  • ₹1.67 CrRevenue · FY 2024 · -16% YoY
  • ₹6.2 LakhNet profit · 4% margin
  • ₹36.4 LakhEBITDA · 22% margin
  • ₹1 LakhPaid-up capital
  • -18%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Vivatest Research And Development Private Limited are on its company page.

Premium access

Detailed financial statements for VivaTest

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about VivaTest

The primary company behind VivaTest, Vivatest Research And Development Private Limited, reported revenue of β‚Ή1.67 Cr for FY 2024, down 16% year on year.

VivaTest is identified as a provider of research-based drug delivery technologies, where services in formulation development, analytical processes, and stability assessments are offered to enhance drug efficacy. Partnerships for BABE studies and dossier services are extended by its experienced directors, positioning it as a comprehensive service provider in pharmaceutical research and outsourcing. Technologies aimed at improving bioavailability and release profiles are supplied, with a focus on end-to-end solutions for global partners.

VivaTest offers Formulation Development and Analytical Development.

VivaTest operates through Vivatest Research And Development Private Limited.

The legal entities of VivaTest currently have 3 directors, including Geeta Radhakrishna Desai, Kirtida Radhakrishna Desai, Analesh Anand Desai.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available